Jeff Yass’s Tiziana Life Sciences TLSA Stock Holding History

Jeff Yass’s Portfolio TLSA Stock Details TLSA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$71.6K	Buy	55,900 +41,200	+280%	+$53.6K	﹤0.01%	12678
2026 Q1	$17.2K	Buy	+14,700	New	+$20.8K	﹤0.01%	12880
2025 Q4	–	Sell	-32,000	Closed	-$69.1K	–	13623
2025 Q3	$69.1K	Buy	+32,000	New	+$59.2K	﹤0.01%	11744
2021 Q4	–	Sell	-16,100	Closed	-$24K	–	13910
2021 Q3	$24K	Buy	+16,100	New	+$29.7K	﹤0.01%	12520
2021 Q1	–	Sell	-12,000	Closed	-$24K	–	12853
2020 Q4	$24K	Buy	+12,000	New	+$37.9K	﹤0.01%	10865

Other funds holding TLSA

DIG

Dauntless Investment Group Etna, New Hampshire $127M AUM 42.43% 1-Year Est. Return

MAWAG

Mid-American Wealth Advisory Group Kansas City, Missouri $277M AUM 6.22% 1-Year Est. Return

Zhang Financial Portage, Michigan $3.42B AUM 23.04% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

Focus Partners Wealth Boston, Massachusetts $97.6B AUM 29.43% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

HSBC Holdings London, United Kingdom $239B AUM 42.32% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Jeff Yass's TLSA Position: Q2 2026 in Review

Jeff Yass sold out of Tiziana Life Sciences (TLSA) in Q2 2026, closing a stake of 17,267 shares — an estimated $22.4K sold.

Jeff Yass first reported a position in TLSA in Q4 2020 and held it in 12 quarters. The position peaked at $136K in Q2 2025. 31 funds tracked by Wall St. Rank hold TLSA as of Q2 2026.

Jeff Yass reported no remaining Tiziana Life Sciences position as of Q2 2026 after selling out during the quarter.
Jeff Yass sold 17,267 Tiziana Life Sciences shares in Q2 2026, an estimated $22.4K.
Jeff Yass first reported a position in Tiziana Life Sciences in Q4 2020 and held it in 12 quarters.
Jeff Yass's Tiziana Life Sciences position peaked at $136K in Q2 2025.
31 funds tracked by Wall St. Rank held Tiziana Life Sciences as of Q2 2026.

Based on Susquehanna International Group's 13F filing for Q2 2026, filed 14 Aug 2026.